Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS Study)

NCT05800951 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT05800951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05800951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS Study)
Lead sponsor
Henry Ford Health System
Phase
Observational
Overall status
Active, not recruiting
Start date
July 22, 2022
Completion date
December 31, 2026
Enrollment
124 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, acute myocardial infarction of left ventricle, acute myocardial infarction of right ventricle (disorder), acute myocardial infarction with st elevation, cardiogenic shock, nstemi, nstemi - non-st segment elevation mi, stemi, stemi - st elevation myocardial infarction